Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMMUNIC-INC-57237730/news/Immunic-Announces-Publication-of-Extended-Data-from-Phase-2-EMPhASIS-Trial-of-Vidofludimus-Calcium-i-46591743/?utm_source=whatsapp&utm_medium=social&utm_campaign=share